
D. Dequanter et al. / Open Journal of Stomatology 1 (2011) 185-188 187
Although neck dissection is the surgical gold standard
for the treatment of cervical lymphatic spread, the upper
mediastinal and paratracheal nodal groups are not rou-
tinely included in the dissection.
However, Welsh et al. [11] initially reported the im-
portance of the paratracheal nodes in lymphatic drainage
of the larynx and hypopharynx. Harrison et al. con-
firmed that carcinomas of the larynx (especially from the
subglottic region), the trachea, and the cervical esopha-
gus are at risk for paratracheal and tracheobronchial
lymph node metastasis and recommended resection of
the manubrium to remove theses lymph nodes and re-
duce the risk for parastomal disease recurrence [5]. We-
ber et al. [7] reported that paratracheal lymph node me-
tastasis were found in 17.6% of the patients with tumors
of the larynx, in 8.3% of the patients with pharyngeal
tumors and, at least, in 71.4% of the patients with tumors
of the esophagus.
Some investigators have suggested that ipsilateral
paratracheal node dissection should be included as part
of a selective neck dissection in all patients with tumors
invading the subglottis, pyriform fossa apex and postcri-
coid region [12].
In our study, all the patients with advanced laryngeal
and hypopharyngeal SCC had a neck dissection extend-
ed to the upper mediastinum. Most patients with hypo-
pharyngeal SCC had positive paratracheal lymph nodes
but only to the ipsilateral side of the primary. All the
patients with hypopharyngeal SCC greater than 35 mm
had paratracheal lymph node metastasis. Furthemore,
paratracheal lymph node metastasis was always associ-
ated with the presence of cervical lymph node metastasis.
In addition, a strong correlation but, unfortunately, not
statistically significant was found between the presence
of paratracheal lymph node metastasis and hypoharyn-
geal tumors.
We recommend that ipsilateral paratracheal node dis-
section should be included as part of a selective neck
dissection in all patients with tumors invading the hypo-
pharynx, certainly in tumors greater than 35 mm.
In terms of survival rates, in a prospective study of 50
patients with carcinoma of the larynx, hypopharynx, and
cervical esophagus, Timon et al. [13] reported that the
rate of paratracheal nodal metastases was 26%. More-
over, they reported that the survival in patients with po-
sitive paratracheal nodes demonstrated a trend towards
poorer survival compared to patients without paratra-
cheal nodal involvement, and concomitant involvement
of both cervical and paratracheal nodal groups was asso-
ciated with the poorest survival propability.
In their study, Weber et al. [7] confirmed that survival
was significantly reduced by the presence of paratra-
cheal lymph nodes. In our study, 50% of the patients
with positive paratracheal nodes died.
In conclusion, there is little controversy about neck dis-
sections in advanced tumors of the larynx and hypo-
pahrynx. A similar situation applies to mediadtinal dis-
section for hypopharyngeal carcinomas, certainly in tu-
mors greater than 35 mm.
REFERENCES
[1] Hoffman, H.T., Karnell, L.H., Funk, G.F., Robinson, R.A.
and Menck, H.R. (1998) The National Cancer Data Base
Report on cancer of the head and neck. Archives of Oto-
laryngology-Head & Neck Surgery, 124, 951-962.
[2] Ho, C.M., Lam, K.H., Wei, W.I., Yuen, P.W., Lam, L.K.
(1993) Squamous cell carcinoma of the hypopharynx—
Analysis of treatment results. Head Neck, 15, 405-412.
doi:10.1002/hed.2880150507
[3] Lefebvre, J.L., Castelain, B., DeLatorre, J.C., Delobelle-
Deroide, A. and Vankemmel, B. (1987) Lymph node in-
vasion in hypopharynx and lateral epilarynx: A prognos-
tic factor. Head & Neck Surgery, 10, 14-18.
doi:10.1002/hed.2890100104
[4] Wei, W.I. (2002) The dilemma of treating hypopharyn-
geal carcinoma: More or less. Archives of Otolaryngol-
ogy-Head & Neck Surgery, 128, 229-232.
[5] Buckley, J.G. and Lemman, K. (2000) Cervical node
metastases in laryngeal and hypopharyngeal cancer: A
prospective analysis of prevalence and distribution. Head
Neck, 22, 280-385.
doi:10.1002/1097-0347(200007)22:4<380::AID-HED11
>3.0.CO;2-E
[6] Harris, H.H. and Butler, E. (1968) Surgical limits in can-
cer of the subglottic larynx. Archives of Otolaryngology,
87, 64-67.
[7] Weber, R.S., Marvel, J., Smith, P., Hankins, P., Wolf, P.
and Goepfert, H. (1993) Paratracheal lymph node dissec-
tion for carcinoma of the larynx, hypopharynx and cer-
vical esophagus. Archives of Otolaryngology-Head &
Neck Surgery, 108, 11-17.
[8] Driscoll, W.G., Nagorsky, M.J., Cantrell, R.W. and Johns,
M.E. (1983) Carcinoma of the pyriform sinus: Analysis
of 102 cases. Laryngoscope, 93, 556-560.
[9] Bataini, J.P., Bernier, J., Brugere, J., Jaulerry, C., Picco,
C. and Brunin, F. (1985) Natural history of neck diseases
in patients with squamous cell carcinoma of oropharynx
and pharyngolarynx. Radiotherapy & Oncology, 21, 245-
255. doi:10.1016/S0167-8140(85)80033-5
[10] Lindberg, R. (1972) Distribution of cervical lymph nodes
metastases from squamous cell carcinoma of the upper
respiratory and digestive tracts. Cancer, 29, 1446-1449.
doi:10.1002/1097-0142(197206)29:6<1446::AID-CNCR
2820290604>3.0.CO;2-C
[11] Welsh, L.W. (1964) The normal human laryngeal lym-
phatics. Annals of Otology, Rhinology, and Laryngology,
73, 569-582.
[12] Harrison, D.F.N. (1975) Laryngectomy for subglottic
lesions. Laryngoscope, 85, 1208-1210.
C
opyright © 2011 SciRes. OJST